Avive Solutions

Executive Summary

Avive Solutions is a San Francisco-based medical device company transforming the emergency response landscape for out-of-hospital cardiac arrest (OHCA). With sudden cardiac arrest claiming over 350,000 lives annually in the U.S., the survival rate remains below 10% largely due to delays in defibrillation. Avive’s flagship product, the Avive Connect AED®, is a compact, connected automated external defibrillator designed to bridge critical gaps in the Chain of Survival. Unlike traditional AEDs, it integrates directly with 911 dispatch systems, enabling real-time location sharing and guided usage. Its rechargeable battery, Wi-Fi, cellular, and GPS connectivity ensure the device is always ready and locatable. The company’s broader mission is to create a coordinated ecosystem that connects bystanders, emergency medical services, and hospitals, thereby reducing response times and increasing survival odds. Avive Solutions has positioned itself at the intersection of medtech and digital health, capitalizing on the growing emphasis on community-based emergency preparedness. While specific funding and revenue figures are undisclosed, the company has likely attracted interest from venture capitalists focused on life-saving technologies. Key challenges include navigating FDA regulations, competing with established defibrillator manufacturers, and driving adoption among municipalities and businesses. Nonetheless, Avive’s emphasis on connectivity and user-centric design offers a compelling value proposition. If successful, the company could become a cornerstone in the fight against sudden cardiac arrest, potentially saving thousands of lives annually.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance or Expansion of Indications60% success
• Q4 2026Strategic Partnership with Major 911 Dispatch Network or EMS Provider50% success
• Q1 2027Series B or C Funding Round to Scale Manufacturing and Sales65% success